Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Catherine Zeta Jones treated for bipolar disorder

Catherine Zeta Jones – the 41-year-old Welsh actor checked into a day clinic in Connecticut for five days earlier this month for the treatment of bipolar disorder. “After dealing with the stress of the past year, Catherine made the decision to check in to a mental health facility for a brief stay to treat her Bipolar II Disorder,” said publicist Cece Yorke said in a statement adding, “She's feeling great and looking forward to starting work this week on her two upcoming films.”

13 Apr 2011

Work, social and family disability affect 50% of patients with bipolar disorder

Such was the conclusion obtained in a study conducted at the University of Granada that was recently awarded a prize in the IV Spain-Portugal Meeting on Therapeutical Adherence held in Oporto.

6 Apr 2011

National Alliance for Research on Schizophrenia and Depression is now Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) continues its 25-year mission to alleviate the suffering of mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.

5 Apr 2011

AA Pharma launches Lithium Carbonate SR 300mg for Bipolar Disorder in Canada

AA Pharma Inc., a leading distributor of pharmaceuticals in Canada, is pleased to announce the launch of LITHMAX, a sustained release formulation containing 300mg of lithium carbonate. LITHMAX is indicated in the treatment of manic episodes of Bipolar Disorder, as well as the maintenance treatment for individuals with a diagnosis of Bipolar Disorder.

30 Mar 2011

Roundup: States 'scrambling' on Medicaid budget; health costs for inmates, Ex-Cons; kids' insurance

Strapped states are scrambling to address Medicaid's ballooning costs before the federal government cuts back a critical source of funding this week. Medicaid is one of state's costliest burdens. And the weak economy swelled the rolls to record numbers. Nearly 49 million people -- or almost one in six Americans -- were covered by the safety net at the end of 2009, the latest figures available.

29 Mar 2011

Genetic link to attempted suicide discovered - Findings could lead to new avenues of treatment

Johns Hopkins scientists, reporting in the journal Molecular Psychiatry, have identified a small region on chromosome 2 that is associated with increased risk for attempted suicide. This small region contains four genes, including the ACP1 gene, and the researchers found more than normal levels of the ACP1 protein in the brains of people who had committed suicide. This protein is thought to influence the same biological pathway as lithium, a medication known to reduce the rate of suicidal behavior.

28 Mar 2011

First Edition: March 22, 2011

Today's headlines include reports about California's health insurance rates and looming insolvency for the U.S. Disability Fund.

22 Mar 2011

Physical ill-health reduces life expectancy of people with severe mental illness

Physical ill-health is rife among the severely mentally ill in Britain, according to new research published today by the University of East Anglia (UEA).

21 Mar 2011

Special report takes critical look at debates about pediatric problematic moods, behaviors

Decisions about whether and how to diagnose children with emotional and behavioral disturbances, and whether and how to treat them, are sometimes not clear-cut. When decisions lie within a "zone of ambiguity," people who emphasize different value commitments can reach different but equally respectable conclusions.

17 Mar 2011

Hazelden, Columbia University to open collegiate addiction recovery residence in N.Y. City

Hazelden, one of the world's largest and most respected private, nonprofit alcohol and drug addiction treatment centers, announced today that it will open a first-of-its-kind collegiate recovery residence called Tribeca Twelve in New York City's Tribeca neighborhood.

17 Mar 2011

Depression: Get a second opinion, 69% of initial diagnoses are incorrect

As he struggled for decades with a depression that often left him despondent, Eric Wilson never thought to get a second opinion.

11 Mar 2011

Top-line results from Repligen RG2417 Phase 2b trial results in patients with bipolar depression

Repligen Corporation announced today results of a Phase 2b clinical trial of RG2417, an oral formulation of uridine, in patients with bipolar depression.

8 Mar 2011

Prevalence of bipolar disorder

Bipolar disorder is a psychiatric disorder that swings between depression and mania. It strikes early and can cause lifelong disability. Reports show that it is chronically undertreated in many low-income countries.

7 Mar 2011

New study provides fascinating insight into genetic basis of bipolar disorder

A new study provides fascinating insight into the genetic basis of bipolar disorder, a highly heritable mood disorder characterized by recurrent episodes of mania and depression.

3 Mar 2011

New research finds link between genomic variants in neurological processes and autism

New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.

2 Mar 2011

New study suggests variation in PCLO gene can contribute to risk of bipolar disorder

Understanding the genetics of bipolar disorder could lead to new treatments, but identifying specific genetic variations associated with this disorder has been challenging.

24 Feb 2011

Forest Labs enters definitive merger agreement to acquire Clinical Data

Forest Laboratories, Inc. and Clinical Data, Inc. today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics, for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd.

22 Feb 2011

Regional brain structural alterations associated with bipolar disorder

Lithium, introduced in the late 1940's, was the first "wonder drug" in psychiatry. It was the first medication treatment for the manic and depressive episodes of bipolar disorder and it remains among one of the most effective treatments for this disorder.

17 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

Ascend Health opens Mother-Infant Outpatient Program to treat post-partum depression

Ascend Health Corporation, through Cedar Hills Hospital, announced the opening of the Mother-Infant Outpatient Program, the first in the Pacific Northwest region where new mothers can receive treatment with their children in a safe, caring and convenient setting. Cedar Hills Hospital is a facility of Ascend Health Corporation.

5 Feb 2011

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Catherine Zeta Jones treated for bipolar disorder

Work, social and family disability affect 50% of patients with bipolar disorder

National Alliance for Research on Schizophrenia and Depression is now Brain & Behavior Research Foundation

AA Pharma launches Lithium Carbonate SR 300mg for Bipolar Disorder in Canada

Roundup: States 'scrambling' on Medicaid budget; health costs for inmates, Ex-Cons; kids' insurance

Genetic link to attempted suicide discovered - Findings could lead to new avenues of treatment

First Edition: March 22, 2011

Physical ill-health reduces life expectancy of people with severe mental illness

Special report takes critical look at debates about pediatric problematic moods, behaviors

Hazelden, Columbia University to open collegiate addiction recovery residence in N.Y. City

Depression: Get a second opinion, 69% of initial diagnoses are incorrect

Top-line results from Repligen RG2417 Phase 2b trial results in patients with bipolar depression

Prevalence of bipolar disorder

New study provides fascinating insight into genetic basis of bipolar disorder

New research finds link between genomic variants in neurological processes and autism

New study suggests variation in PCLO gene can contribute to risk of bipolar disorder

Forest Labs enters definitive merger agreement to acquire Clinical Data

Regional brain structural alterations associated with bipolar disorder

Repligen third quarter total revenue increases 26% to $7,068,000

Ascend Health opens Mother-Infant Outpatient Program to treat post-partum depression

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in